The hERG inhibition at a concentration of 1uM of a compound with the SMILES C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CC(C)O)nn3)CC2)nc(N2CCN(C(=O)[C@H](C)n3cc(CCC[NH+]=C(N)N)nn3)CC2)n1.[Cl-] is 11.875\%.
The {herg_central_at_1uM__names__noun} of a {#drug|compound!} with the {SMILES__description} {SMILES#} is {herg_central_at_1uM#}{herg_central_at_1uM__units}.
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CC(C)O)nn3)CC2)nc(N2CCN(C(=O)[C@H](C)n3cc(CCC[NH+]=C(N)N)nn3)CC2)n1.[Cl-]
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CC(C)O)nn3)CC2)nc(N2CCN(C(=O)[C@H](C)n3cc(CCC[NH+]=C(N)N)nn3)CC2)n1.[Cl-]
diaminomethylidene-[3-[1-[(2S)-1-[4-[4-[4-[2-[4-(2-hydroxypropyl)triazol-1-yl]acetyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-1-oxopropan-2-yl]triazol-4-yl]propyl]azanium;chloride